[go: up one dir, main page]

WO2006012779A8 - Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical - Google Patents

Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical

Info

Publication number
WO2006012779A8
WO2006012779A8 PCT/CN2004/000907 CN2004000907W WO2006012779A8 WO 2006012779 A8 WO2006012779 A8 WO 2006012779A8 CN 2004000907 W CN2004000907 W CN 2004000907W WO 2006012779 A8 WO2006012779 A8 WO 2006012779A8
Authority
WO
WIPO (PCT)
Prior art keywords
production
indeca
wikstroemia
extract
inflammatory pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2004/000907
Other languages
French (fr)
Chinese (zh)
Other versions
WO2006012779A1 (en
Inventor
Liyan Wang
Susumu Kitanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon University
Original Assignee
Nihon University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon University filed Critical Nihon University
Priority to CN2004800437624A priority Critical patent/CN101014560B/en
Priority to PCT/CN2004/000907 priority patent/WO2006012779A1/en
Publication of WO2006012779A1 publication Critical patent/WO2006012779A1/en
Anticipated expiration legal-status Critical
Publication of WO2006012779A8 publication Critical patent/WO2006012779A8/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to extracts from wilstroemia indeca C.A.Mey, the preparation method and pharmaceutical uses thereof, the formula (1) of the extracted active compound.
PCT/CN2004/000907 2004-08-06 2004-08-06 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical Ceased WO2006012779A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2004800437624A CN101014560B (en) 2004-08-06 2004-08-06 wikstroemia indica extract, preparation method thereof and application thereof in preparing anti-inflammatory drugs
PCT/CN2004/000907 WO2006012779A1 (en) 2004-08-06 2004-08-06 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2004/000907 WO2006012779A1 (en) 2004-08-06 2004-08-06 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical

Publications (2)

Publication Number Publication Date
WO2006012779A1 WO2006012779A1 (en) 2006-02-09
WO2006012779A8 true WO2006012779A8 (en) 2007-04-19

Family

ID=35786866

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/000907 Ceased WO2006012779A1 (en) 2004-08-06 2004-08-06 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical

Country Status (2)

Country Link
CN (1) CN101014560B (en)
WO (1) WO2006012779A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100463906C (en) * 2007-03-07 2009-02-25 哈尔滨医科大学附属第二医院 Extraction method of sipratin
CN101601666B (en) * 2009-07-10 2011-05-25 暨南大学 Liogewang extract and its preparation method and use
CN102344454B (en) * 2011-08-01 2013-11-06 广东药学院 Wikstroemia indica (L.) C.A.Mey extract as well as preparation method and application thereof
CN102311415B (en) * 2011-09-29 2013-06-26 广东药学院 A method for extracting siratin from Liaogewang
CN105315147A (en) * 2014-08-03 2016-02-10 江苏康缘药业股份有限公司 Guaiane-type sesquiterpenoids compound, and preparation method and application thereof
WO2025198923A1 (en) * 2024-03-18 2025-09-25 Curanex Pharmaceuticals Inc. Plant extract compositions and uses thereof
WO2025198994A1 (en) * 2024-03-18 2025-09-25 Warburg Sanders, Inc. Plant extract compositions and uses thereof for treating central nervous system diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1181832C (en) * 1998-10-23 2004-12-29 深圳中药及天然药物研究中心 Anti-AIDS Liaogewang extract and its preparation method, medicine and application

Also Published As

Publication number Publication date
CN101014560A (en) 2007-08-08
WO2006012779A1 (en) 2006-02-09
CN101014560B (en) 2010-04-28

Similar Documents

Publication Publication Date Title
WO2007146248A3 (en) Stable laquinimod preparations
WO2006119498A3 (en) Pharmaceutical compositions with synchronized solubilizer release
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
WO2007052289A3 (en) Novel dispersible tablet composition
WO2007103435A3 (en) Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2009077188A8 (en) Tea composition and process for the manufacture thereof
WO2003014079A8 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
TNSN08284A1 (en) Masking the taste of powders
WO2009051460A3 (en) Peptide coupled ascorbic acid derivatives
WO2005115470A3 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER
WO2005040171A8 (en) Pyrazolo and imidazo-pyrimidine derivatives
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
WO2006012779A8 (en) Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical
WO2007002666A3 (en) Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
WO2007062338A3 (en) Solid formulations
WO2008023003A8 (en) Drug combinations for treating airway diseases
WO2005054222A3 (en) Flavonoid derivative
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
WO2005112914A3 (en) Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
WO2007144699A3 (en) Process for the preparation of alfuzosin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 200480043762.4

Country of ref document: CN

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase